The close timing of these symptoms onset with the initiation of semaglutide, and their significant improvement within 11 days of discontinuing the medication, underscores a potential causal relationship between semaglutide and the rapid onset of depressive symptoms
extended-release formulations
Better Care Services now offers GLP-1 prescriptions At the close of 2025, 1 in 18 American adults said they were currently taking a GLP-1 for weight loss, diabetes management, or another condition, according to a survey by health policy research firm KFF
Neurol Lett 4(1):16 Group A-REDSR (2004) Impact of antioxidants, zinc, and copper on cognition in the elderly: a randomized, controlled trial
Electronic health records from 67 health care organizations across the United States were examined